Patent · US Active

IRE1α inhibitors and uses thereof

US11840523B2 · kind B2 · utility

0Cited by

1References

17Claims

0Family size

Assignees

The Regents of the University of California · US
University of Washington · US

Inventors

Feroz R. Papa · Oakland, US
Bradley Backes · San Francisco, US
Dustin J. Maly · Seattle, US

Key dates

Filing date	Nov 12, 2021
Grant date	Dec 12, 2023
Priority date	—
Expiry date	Nov 12, 2041

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D401/10
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

Disclosed herein, inter alia, are substituted quinazolin-2-amines and isoquinolin-3-amines for inhibiting IRE1α and uses thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.